News Updates For The Ozempic Litigation July 1, 2026: GLP-1 MDL Grows as More Patients Claim They Were Not Told About Side Effects of Ozempic, Other Drugs 85 more lawsuits have joined the MDL against companies that made Ozempic and other GLP-1 drugs
This is due to its dual benefits in managing blood sugar levels and contributing to weight loss, which could lead to reduced healthcare costs overall
But meanwhile, many physicians and researchers are raising concerns
The potential of TMAO to result in atherogenic effects is linked to alterations in cholesterol and bile acid metabolism, inflammatory pathway activation, and foam cell formation promotion
Set point resistance : Your body defends against further weight loss through hormonal shifts, including changes in leptin, ghrelin, and insulin sensitivity, that increase hunger and slow metabolism
Please consult with your doctor get specialist opinion before use, if you suffer from any serious skin conditions